IBt inks IBA distribution deal

Radiotherapy and brachytherapy implant developer International Brachytherapy (IBt) of Seneffe, Belgium, has signed a distribution agreement with radioisotope manufacturer and nuclear medicine products firm Ion Beam Applications (IBA) of Louvain-la-Neuve, Belgium.

The agreement grants IBt exclusive distribution rights for IBA's Visicoil product in the U.K., Ireland, Belgium, Luxembourg, the Netherlands, and France, as well as a nonexclusive distribution right in Austria.

Visicoil is a gold marker used in image-guided radiation therapy (IGRT) procedures that can be implanted to allow more accurate targeting and higher dose deliveries, according to IBt.

By AuntMinnie.com staff writers
April 18, 2007

Related Reading

IBA increases sales and profit in 2006, March 15, 2007

IBA to install cyclotron in India, February 26, 2007

IBA expands production capacity, January 19, 2007

IBA nets U.S. proton therapy order, January 8, 2007

IsoRay, IBt notch technology agreement, January 3, 2006

Copyright © 2007 AuntMinnie.com

Page 1 of 1262
Next Page